Taurine Sleep Quality Randomized Trial Evidence Table

Structured evidence table for Taurine Sleep Quality Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Taurine Sleep Quality Randomized TrialCirrhosis is a major and growing global cause of morbidity and premature mortality, driven largely by alcohol-associated liver disease and metabolic dysfunction–associated steatotic liver disease alongside chronic viral hepatitis.2Sasidharan Swarup (2026)A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
Taurine Sleep Quality Randomized TrialFatigue in chronic liver disease is a multidimensional syndrome involving reduced physical and mental energy, impaired motivation, reduced endurance, and slowed cognition that is often poorly relieved by rest.2Sasidharan Swarup (2026)A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
Taurine Sleep Quality Randomized Trial, , Despite its impact, there is no universally effective, guideline-endorsed pharmacologic therapy for fatigue in cirrhosis.2Sasidharan Swarup (2026)A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
Taurine Sleep Quality Randomized TrialAs the cirrhosis population ages and lives longer with decompensation, the clinical focus can no longer remain limited to “hard” outcomes (bleeding, ascites, and encephalopathy) alone; patient-reported outcomes and day-to-day functioning matter because they determine disability, health care use, and whether patients can participate meaningfully in care pathways.2Sasidharan Swarup (2026)A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
topicTaurine Sleep Quality Randomized Trial
claimCirrhosis is a major and growing global cause of morbidity and premature mortality, driven largely by alcohol-associated liver disease and metabolic dysfunction–associated steatotic liver disease alongside chronic viral hepatitis.
evidence level2
citationSasidharan Swarup (2026)
sourceA randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
topicTaurine Sleep Quality Randomized Trial
claimFatigue in chronic liver disease is a multidimensional syndrome involving reduced physical and mental energy, impaired motivation, reduced endurance, and slowed cognition that is often poorly relieved by rest.
evidence level2
citationSasidharan Swarup (2026)
sourceA randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
topicTaurine Sleep Quality Randomized Trial
claim, , Despite its impact, there is no universally effective, guideline-endorsed pharmacologic therapy for fatigue in cirrhosis.
evidence level2
citationSasidharan Swarup (2026)
sourceA randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis
topicTaurine Sleep Quality Randomized Trial
claimAs the cirrhosis population ages and lives longer with decompensation, the clinical focus can no longer remain limited to “hard” outcomes (bleeding, ascites, and encephalopathy) alone; patient-reported outcomes and day-to-day functioning matter because they determine disability, health care use, and whether patients can participate meaningfully in care pathways.
evidence level2
citationSasidharan Swarup (2026)
sourceA randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis

Source documents

  1. A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis